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Joubert syndrome (JS) is an autosomal recessive developmental brain condition characterized by hypoplasia/dysplasia
of the cerebellar vermis and by ataxia, hypotonia, oculomotor apraxia, and neonatal breathing dysregulation. A
form of JS that includes retinal dysplasia and cystic dysplastic kidneys has been differentiated from other forms of
JS, called either “JS type B” or “cerebello-oculo-renal syndrome” (CORS), but the genetic basis of this condition
is unknown. Here, we describe three consanguineous families that display CORS. Linkage analysis deﬁnes a novel
locus on chromosome 11p12-q13.3, with a maximum two-point LOD score of at the marker D11S1915.Zp 5.2
Therefore, the cerebello-oculo-renal form of JS is a distinct genetic entity from the Joubert syndrome 1 (JBTS1)
locus described elsewhere, in which there is minimal involvement of retina or kidney. We suggest the term “CORS2”
for this new locus.
Joubert syndrome (JS) (also known as “Joubert-Bolts-
hauser syndrome”) is a rare autosomal recessive syndrome
characterized by hypoplasia/dysplasia of the cerebellar
vermis. It was ﬁrst described in 1968 by Maria Joubert
and colleagues (Joubert et al. 1968) as “a syndrome of
familial dysgenesis of the vermis accompanied by hyper-
ventilation, abnormal eye movements, and retardation.”
Genetic mapping studies in two Middle Eastern families
have identiﬁed one locus for classical JS on chromosome
9q34.3, named “JBTS1” (MIM 213300), deﬁning a can-
didate interval of 13 cM (Saar et al. 1999). Two other
families with JS presented in this study and four addi-
tional families ascertained by our group (Keeler et al.
2001) showed recombinations through the candidate in-
terval, which suggests that JS is likely to be genetically
heterogeneous. No causative genes for JS or related con-
ditions have been identiﬁed to date.
Ocular and renal features are often seen in conjunction
with JS that together constitute the cerebello-oculo-renal
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syndromes (Satran et al. 1999) and are likely genetically
distinct from classical JS. Ocular involvement includes
Leber congenital amaurosis (LCA [congenital rod-cone
dystrophy]) and coloboma (a ﬁssure of the eye epithe-
lium). Renal involvement includes cystic dysplastic kidney
disease (CDK) and nephronophthisis (NPHP). The form
of JS with ocular or renal involvement has been called
“type B” (Hildebrandt et al. 1992) or “type II” (King and
Stephenson 1984; King et al. 1984). There is signiﬁcant
overlap of these syndromes with both Dekaban-Arima
(DAS [incorporating LCA plus CDK] [MIM 243910])
and Senior-Lo¨ken syndromes (SLS [incorporating LCA
plus NPHP] [MIM 266900]). In fact, several patientswith
DAS or SLS display the radiographic hallmarks of JS,
including cerebellar vermis hypoplasia (Satran et al.
1999), which further suggests overlap in these syndromes.
However, in a study of 11 patients with JS type B, none
displayed mutations in the NPHP1 gene that are iden-
tiﬁed in some patients with SLS (Hildebrandt et al. 1998).
These data suggest that JS type B may be genetically dis-
tinct from classical JS, as well as from DAS and SLS.
The “molar-tooth” sign on brain imaging (MTI) is an
additional radiographic feature that may help narrow the
phenotypic spectrum of the disorder. It is found in the
majority of patients with clinical and radiographic fea-
tures of JS (Maria et al. 1999b) and is one of the diag-
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Figure 1 Pedigree and haplotype analysis for markers on chromosome 11p12-q13.3 for families 002, 006, and 129. Blackened symbols
represent affected individuals; the triangle represents a deceased fetus.
nostic hallmarks. The patients originally described by
Dr. Joubert also display this feature (Andermann et al.
1999), and it was present in at least one of the families
mapping to chromosome 9q34.3. The MTI represents a
constellation of anatomic brain malformations that to-
gether result in the brainstem isthmus and upper pons
taking on the appearance of a “molar tooth” on axial
brain MRI. These malformations include a deep inter-
peduncular fossa at the level of the isthmus and upper
pons; elongated, thick, and maloriented superior cere-
bellar peduncles; and hypoplasia/aplasia/dysplasia of the
superior cerebellar vermis (Maria et al. 1997).
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Figure 2 Two-point LOD scores performed with MLINK for families 002, 006, and 129 across the genetic interval. Markers are listed
according their genetic position in cM.
Table 1
Two-Point LOD Scores on Chromosome 11p12-11q13.3
for Families 002, 006, and 129 at vp 0.0–0.4
Marker
LOD Score at v p
0 .05 .1 .2 .3 .4
D11S1993 4.3419 3.146 2.883 2.071 1.205 .463
D11S871 4.3419 2.605 2.379 1.646 .872 .265
D11S986 3.151 2.71 2.276 1.449 .737 .235
D11S1303 2.831 2.485 2.138 1.453 .817 .299
D11S2365 3.186 2.785 2.381 1.581 .838 .261
D11S1915 5.238 4.653 4.058 2.856 1.693 .683
D11S1326 3.831 3.356 2.88 1.95 1.101 .422
D11S2363 4.272 3.789 3.296 2.295 1.326 .502
D11S1368 4.434 3.879 3.319 2.202 1.159 .355
D11S4459 2.971 2.613 2.253 1.539 .872 .324
D11S2005 3.186 2.785 2.381 1.581 .838 .261
D11S2006 4.434 3.879 3.319 2.202 1.159 .355
D11S956 5.034 4.459 3.876 2.707 1.586 .626
D11S1286 .823 .692 .567 .348 .179 .064
D11S1296 1.757 2.664 2.498 1.852 1.102 .427
D11S971 .72 .349 .444 .367 .208 .066
D11S1369 1.757 2.644 2.462 1.795 1.046 .398
D11S2371 1.184 .111 .025 .045 .002 .027
D11S2002 1.544 1.04 1.153 .83 .386 .067
D11S2000 1.3020 1.606 .506 .18 .246 .123
We ascertained DNA samples from affected and un-
affected individuals from 20 families—16 of which have
a history of consanguinity—that met diagnostic criteria
for JS (Maria et al. 1999a). The ﬁrst 13 families enrolled
in our study were analyzed by genome scan, two of which
were consanguineous and displayed JS plus oculo-renal
involvement (families 002 and 006). Eighty-seven samples
and controls were analyzed for 374 polymorphic markers
(Marshﬁeld Center for Medical Genetics Screening Set
11), with an average spacing of 10 cM, which gave a
total of ∼32,500 genotypes. The results from families 002
and 006 were analyzed separately from those of the re-
maining families without evidence of extra-CNS involve-
ment. Two-point linkage analysis was performed using
the MLINK component of the LINKAGE computer pro-
gram (Lathrop et al. 1985), under the assumption of an
autosomal recessive inheritance pattern, disease allele
frequency set at 0.001 with full penetrance, and equal
allele frequencies. LOD scores were calculated at vp 0
and 0.1 for each marker.
Only one locus was identiﬁed from the analysis of
families 002 and 006, with a combined peak two-point
LOD score for marker D11S1985, at 11p12-Zp 3.4
q13.3. At this locus, Z was positive in ﬁve sequential
markers from the screening set in these two families. No
other loci were identiﬁed with for families 002 andZ 1 2
006, and the 11p12-q13 locus was excluded in the re-
maining informative families without extra-CNS involve-
ment. Analysis of these ﬁvemarkers in ﬁve additional con-
sanguineous multiplex families with JS plus clear evidence
of oculo-renal involvement, which were ascertained sub-
sequent to the genome scan, identiﬁed one additional
family (family 129) mapping to 11p12-q13.
Additional markers in this region were selected at 1–3
cM intervals, on the basis of theGenomeDatabase genetic
map and the Human Genome Browser physical map.
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Figure 3 Genetic map across the CORS2 candidate interval
11p12-q13.3.
Genotypes were analyzed by denaturing gel electropho-
resis. All seven affected children from the three families
were homozygous for 12 sequential markers in this in-
terval. In contrast, none of the parents or unaffected sib-
lings were homozygous for these haplotypes (ﬁg. 1). The
diseased haplotypes do not appear to be shared among
the three families, at least at this resolution, as there is
no evidence of allele sharing among the affected mem-
bers at this locus. A maximum two-point LOD score of
at was identiﬁed for marker D11S1915,Zp 5.23 vp 0
with all other markers in the surrounding region pro-
ducing positive scores as high as 5.03 (table 1; ﬁg. 2).
Recombinations were identiﬁed in D11S871 and
D11S1296, which produced a minimal candidate inter-
val of ∼29 cM encompassing ∼30Mbp (ﬁg. 3), including
a 5-Mbp, currently unsequenced gap at the centromere.
The candidate interval contains ∼500 known or predicted
genes, many of which are expressed in the developing
human brain. TheMIM gene list includes the developing
brain-expressed genes EHF, MDK, and CTNND1,which
are thought to play diverse roles. ALX4, SCA5, NNO1,
SLO, SPG17, and BBS1 are disease loci on chromosome
11 that at least partially overlap this interval and that
involve a brain phenotype, but insufﬁcient clinical over-
lap is present to suggest allelic variation with this locus.
These data suggest that identiﬁcation of the causative
gene will require further reﬁnement of the candidate in-
terval and analysis of multiple candidate genes.
The affected members of these three families display
the oculo-renal form of JS (JS type B). Family 002 is from
northern Pakistan, and the parents are ﬁrst cousins. The
living child displays the characteristic breathing abnor-
mality, hypotonia, ataxia, and oculomotor apraxia, the
hallmarks of JS. Brain images are not available. He has
moderate visual impairment but no obvious retinopathy,
although an electroretinogram has not been performed.
A renal ultrasound showed generalized increased echo-
genicity, with multiple small cysts throughout, and loss
of the normal cortico-medullary differentiationbilaterally.
There were no liver, digit, tongue, cardiac, or hormonal
abnormalities. A deceased fetus showed a posterior en-
cephalocele with a cerebellarmalformation, not otherwise
speciﬁed. The kidneys were abnormal, with cystic dilata-
tion of the collecting ducts, but no further information
is available. Family 006 is from the United Arab Emir-
ates, and the parents are ﬁrst cousins. The mother had
six pregnancies with two affected children. The 15-year-
old affected child had hydrocephalus at birth, requiring
a ventriculoperitoneal shunt. Facial dysmorphic features
included a depressed nasal bridge with hypertelorism,
high-arched palate, and low-set ears. There were no ab-
normal eye movements or panting respirations in the
neonatal period, although she displayed severe hypo-
tonia and developmental delay. Brain MRI showed the
MTI, absence of the cerebellar vermis, and abnormal
kinked corpus callosum (ﬁg. 4). The occipital cortex ap-
peared malformed, with possible polymicrogyria. Oph-
thalmological examination showed double contoured
coloboma of the retina and choroid below the optic disk,
as well as optic atrophy and impaired vision, although
an electroretinogram was not performed. The 5-year-old
affected child had an enlarged head circumference at
birth and required a ventriculoperitoneal shunt for hy-
drocephalus at age 14 mo. She had similar facial dys-
morphisms, as well as panting respirations, jerky eye
movements, hypotonia, and mental retardation. Brain
MRI showed theMTI, thin corpus callosum, and possibly
malformed occipital cortex. Ophthalmological examina-
tion showed bilateral coloboma of the optic-nerve head.
Abdominal ultrasound in both affected children showed
normal-sized liver and kidneys. In the younger affected
child, there was evidence of calciﬁcation at the renal
pyramid, suggestive of nephrocalcinosis, but no renal
cysts were identiﬁed that would be suggestive of NPHP
or CDK. A karyotype in both children was normal. Fami-
ly 129 is from the United Arab Emirates and displays
consanguinity, with three affected children. This family
was reported elsewhere as family B (Saar et al. 1999).
Breathing was abnormal, with panting respirations, in
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Figure 4 Brain MRI from family 006, demonstrating the key radiographic ﬁndings in JS in the older (A and B) and younger (C and D)
affected children. A and C, T2-weighted axial images, demonstrating the MTI, with a deep interpeduncular fossa (arrowhead), absence of the
cerebellar vermis (arrow), and enlarged 4th ventricle (asterisk). B and D, T1-weighted saggital images, demonstrating a maloriented superior
cerebellar peduncle (arrow). Additional abnormalities in these children include kinked (B) or thin (D) corpus callosum (arrowheads) and a possible
occipital gyral malformation (asterisk).
the neonatal period in all three affected children. Hy-
potonia, ataxia, and abnormal eye movement were seen
in all. Brain MRI showed absence of the cerebellar ver-
mis, but images are not available. All three had retinal
dystrophy andmoderate visual impairment. A renal ultra-
sound was normal in all three, and there were no renal
symptoms. Tongue tumors, hydrocephalus, polydactyly,
pituitary abnormalities, seizures, diabetes, and cardiac
abnormalities were absent.
The three families reported here display the oculo-renal
form of JS, with kidney cysts in family 002, coloboma in
family 006, and retinopathy in family 129. The children
from all three families had evidence of visual impairment,
although electroretinograms were not performed, and,
thus, the diagnosis of LCA is not certain. Coloboma has
been reported in several patients with JS (Kher et al.
1994; Dahlstrom et al. 2000) and can be seen as part
of DAS and COACH (hypoplasia of cerebellar vermis,
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oligophrenia, congenital ataxia, coloboma, and hepatic
ﬁbrosis) syndromes (Gentile et al. 1996), as well as other
JS variants (Gleeson et al., in press). The phenotypic
variability between these two families suggests that there
may be genetic modiﬁers that inﬂuence both the disease
severity and feature expressivity.
We suggest the name “CORS2” for this new locus
because of the apparently frequent association of oculo-
renal involvement in affected individuals. We infer that
a gene mutation within this locus is responsible for at
least some of the cases of JS type B. The affected mem-
bers from these families display the JS spectrum of dis-
orders but with a phenotype that is largely distinct from
that seen in patients mapping to the JBTS1 locus. Only
one member of one of the two families linked to 9q34.3
displayed retinopathy (Sztriha et al. 1999), and none of
the patients displayed coloboma or renal abnormalities.
Therefore, although there may be some overlap in the
phenotypic spectrum of these conditions, they appear to
be largely distinct, and, thus, we prefer distinct nomen-
clature. We anticipate that there might be some overlap
in the phenotypic spectrum of JBTS1 with CORS, and,
thus, we have reserved the alternative term “CORS1”
for JBTS1.
While this manuscript was in preparation, we learned
that a second group had independently identiﬁed the
CORS2 locus in a large inbred European pedigree with
JS type B (Valente et al. 2003 [in this issue]), which
provides independent veriﬁcation of the relevance of this
CORS2 locus in the CORS phenotype. The full pheno-
typic spectrum of disease that relates to CORS2will need
to be further examined, as the relatively small number
of patients represented in these studies likely do not en-
compass the full range of clinical variability associated
with this locus.
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